EUVIMEDEUVIMED entdecken
Open Access

Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

Troy M Robinson iD, Robert L Bowman iD, Sonali Persaud, Ying Liu, Rosemary Neigenfind, Qi Gao, Jingping Zhang, Xiaotian Sun, Linde A Miles iD, Sheng F Cai iD, Adam Sciambi iD, Aaron Llanso iD und 6 weitere

Science Advances · 22.09.2023 · 9 (38)

DOI: 10.1126/sciadv.adg0488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 22.09.2023. Verfasst von Troy M Robinson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measurable residual disease (MRD), defined as the population of cancer cells that persist following therapy, serves as the critical reservoir for disease relapse in acute myeloid leukemia and other malignancies. Understanding the biology enabling MRD clones to resist therapy is necessary to guide the development of more effective curative treatments. Discriminating between residual leukemic clones, preleukemic clones, and normal precursors remains a challenge with current MRD tools. Here, we developed a single-cell MRD (scMRD) assay by combining flow cytometric enrichment of the targeted precursor/blast population with integrated single-cell DNA sequencing and immunophenotyping. Our scMRD assay shows high sensitivity of approximately 0.01%, deconvolutes clonal architecture, and provides clone-specific immunophenotypic data. In summary, our scMRD assay enhances MRD detection and simultaneously illuminates the clonal architecture of clonal hematopoiesis/preleukemic and leukemic cells surviving acute myeloid leukemia therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansBiological AssayFlow CytometryGenotypeImmunophenotyping

Autor:innen und Institutionen

  • Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology and Laboratory Medicine, Molecular Diagnostic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Troy M Robinson, Robert L Bowman, Linde A Miles, Sheng F Cai, Adam Sciambi, Aaron Llanso, Aaron Goldberg, Ahmet Dogan, Ross L Levine, Wenbin Xiao

Förderung

  • NCI NIH HHS

Zitieren

APA

Robinson, T. M., Bowman, R. L., Persaud, S., Liu, Y., Neigenfind, R., Gao, Q., Zhang, J., Sun, X., Miles, L. A., Cai, S. F., Sciambi, A., Llanso, A., Famulare, C., Goldberg, A., Dogan, A., Roshal, M., Levine, R. L., & Xiao, W. (2023). Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia. Science Advances, 9(38). https://doi.org/10.1126/sciadv.adg0488

Vancouver

Robinson TM, Bowman RL, Persaud S, Liu Y, Neigenfind R, Gao Q, et al. Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia. Science Advances. 2023;9(38). doi:10.1126/sciadv.adg0488

BibTeX
@article{Robinson2023,
  author = {Robinson, Troy M and Bowman, Robert L and Persaud, Sonali and Liu, Ying and Neigenfind, Rosemary and Gao, Qi and Zhang, Jingping and Sun, Xiaotian and Miles, Linde A and Cai, Sheng F and Sciambi, Adam and Llanso, Aaron and Famulare, Christopher and Goldberg, Aaron and Dogan, Ahmet and Roshal, Mikhail and Levine, Ross L and Xiao, Wenbin},
  title = {Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {38},
  doi = {10.1126/sciadv.adg0488}
}
Kostenlos starten →